Supernus Pharmaceuticals
Social media
Supernus Pharmaceuticals Logo
About Supernus Pharmaceuticals
Supernus Pharmaceuticals Inc is a specialty biopharmaceutical company focused on developing and commercializing proprietary therapies for central nervous system (CNS) diseases and disorders. Its portfolio includes approved products for conditions such as ADHD, epilepsy, Parkinson's disease, migraine, and cervical dystonia, including Qelbree, GOCOVRI, Oxtellar XR, APOKYN, Trokendi XR, XADAGO, and MYOBLOC. The company also has a pipeline of clinical and preclinical candidates targeting CNS disorders such as epilepsy, depression, and ADHD. Supernus markets its products through pharmaceutical wholesalers, specialty pharmacies, and distributors in the United States.
Address
9715 Key West Avenue,
Rockville, 20850
United States
Year founded
2005
Number of employees
600-700
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Report inaccurate data
Request an update to help us keep the brand up-to-date.
